Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 59.94 USD -0.61% Market Closed
Market Cap: 2.9B USD

Relative Value

The Relative Value of one PBH stock under the Base Case scenario is hidden USD. Compared to the current market price of 59.94 USD, Prestige Consumer Healthcare Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PBH Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
69
vs Industry
32
Median 3Y
2.9
Median 5Y
2.7
Industry
2.6
Forward
2.6
vs History
55
vs Industry
24
Median 3Y
15.2
Median 5Y
14.8
Industry
21.7
Forward
13
vs History
76
vs Industry
26
Median 3Y
13.3
Median 5Y
12.6
Industry
16.6
vs History
36
vs Industry
19
Median 3Y
-51.4
Median 5Y
12.9
Industry
22.5
vs History
88
vs Industry
32
Median 3Y
2
Median 5Y
1.9
Industry
2.3
vs History
93
vs Industry
26
Median 3Y
4
Median 5Y
4
Industry
2.9
Forward
3.4
vs History
92
vs Industry
25
Median 3Y
7.2
Median 5Y
7
Industry
5.5
vs History
92
vs Industry
26
Median 3Y
12.6
Median 5Y
12.4
Industry
13.1
Forward
10.2
vs History
77
vs Industry
27
Median 3Y
12.9
Median 5Y
12.9
Industry
16.6
Forward
11
vs History
92
vs Industry
22
Median 3Y
18.5
Median 5Y
17.7
Industry
15.8
vs History
95
vs Industry
22
Median 3Y
19.1
Median 5Y
18.5
Industry
19.1
vs History
80
vs Industry
42
Median 3Y
1.4
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

PBH Competitors Multiples
Prestige Consumer Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Prestige Consumer Healthcare Inc
NYSE:PBH
2.9B USD 2.6 14.4 10.5 11.4
US
Eli Lilly and Co
NYSE:LLY
929B USD 15.6 50.5 33.9 36.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
481.1B USD 5.2 19.2 15.7 20.4
CH
Roche Holding AG
SIX:ROG
251.1B CHF 4.1 26.6 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.8 29.8 108.1 158.2
CH
Novartis AG
SIX:NOVN
205B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
241B USD 3.8 12.7 9.1 10.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9 10.4
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
144B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
Prestige Consumer Healthcare Inc
NYSE:PBH
Average P/E: 22
14.4
4%
3.6
US
Eli Lilly and Co
NYSE:LLY
50.5
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.2
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.6
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
12.7
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Prestige Consumer Healthcare Inc
NYSE:PBH
Average EV/EBITDA: 398.5
10.5
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
33.9
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.7
9%
1.7
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.1
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Prestige Consumer Healthcare Inc
NYSE:PBH
Average EV/EBIT: 1 708.5
11.4
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.4
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.2
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.7
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
1%
10.4
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3